Search for: "WYETH PHARMACEUTICALS COMPANY" Results 61 - 80 of 548
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Feb 2014, 1:03 pm by Roy Black
The government alleges that right after Martoma received the confidential information, SAC sold off $700 million in positions in pharmaceutical giants Elan and Wyeth to avoid a huge loss, and then shorted the stock to realize an additional profit of $276 million. [read post]
29 Jan 2014, 3:31 pm
Wyeth, the majority rejected the claim that inadequate warnings and manufacturing defects are the only claims against pharmaceutical companies that are viable. [read post]
9 Dec 2013, 7:06 am by Rebecca Tushnet
”  But, though some federal courts interpreting Pennsylvania law have reasoned that justifiable reliance/causation can’t be present when the pharmaceutical company didn’t sell directly to the patient, this “threatens to swallow up any cause of action brought against a drug manufacturer for failure to warn, as every claim—whether derived from statute or common-law tort—includes an element of causation or justified reliance. [read post]
31 Oct 2013, 5:00 am
  The facts sound rather like Wyeth v. [read post]
19 Sep 2013, 9:53 am by Bexis
  By itself, off-label promotion is no more causal than, as we commented the other day, a “video of a company employee kicking his dog. [read post]
9 Aug 2013, 2:36 pm by Jonathan Tycko
Campbell is a former Wyeth sales representative who worked for the company for twenty years. [read post]
31 Jul 2013, 8:04 pm
Wyeth Pharmaceuticals Inc., (now owned by Pfizer) a pharmaceutical company has agreed to pay $490.9 million to resolve the unlawful marketing of the prescription drug Rapamune. [read post]
31 Jul 2013, 7:04 pm by The Borchardt Law Firm, PLLC
Wyeth Pharmaceuticals Inc., (now owned by Pfizer) a pharmaceutical company has agreed to pay $490.9 million to resolve the unlawful marketing of the prescription drug Rapamune. [read post]
31 Jul 2013, 7:04 pm by The Borchardt Law Firm, PLLC
Wyeth Pharmaceuticals Inc., (now owned by Pfizer) a pharmaceutical company has agreed to pay $490.9 million to resolve the unlawful marketing of the prescription drug Rapamune. [read post]
31 Jul 2013, 7:04 pm by The Borchardt Law Firm, PLLC
Wyeth Pharmaceuticals Inc., (now owned by Pfizer) a pharmaceutical company has agreed to pay $490.9 million to resolve the unlawful marketing of the prescription drug Rapamune. [read post]
31 Jul 2013, 7:04 pm by The Borchardt Law Firm, PLLC
Wyeth Pharmaceuticals Inc., (now owned by Pfizer) a pharmaceutical company has agreed to pay $490.9 million to resolve the unlawful marketing of the prescription drug Rapamune. [read post]
22 Jul 2013, 7:35 am by Andrew R. Trafford
 In the first set of charges, an employee of CR Intrinisic (an SAC Capital affiliate) allegedly used non-public clinical trial results of two pharmaceutical companies, Elan and Wyeth. [read post]
5 Jul 2013, 5:00 am by Bexis
Wyeth, Inc., 37 A.3d 549, 570 (New Jersey Super. [read post]
26 Jun 2013, 6:30 am by Gene Quinn
Pfizer subsidiary Wyeth and Takeda will divide the proceeds of the settlement with Pfizer receiving $1.376 billion and Takeda receiving $774 million. [read post]
5 Jun 2013, 5:29 am by Schachtman
Sander Greenland and others have raised various theoretical objections to the argument that relative risks should exceed two before attribution can be made in specific cases. [read post]